This is with reference to our prior intimation dated December 16, 2025, wherein we had informed the Exchange about the meeting of the Board of Directors of Dr Lalchandani Labs Limited ('the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Limited has deferred its Board Meeting originally scheduled for December 22, 2025, which was supposed to consider and approve matters related to the proposed Rights Issue, including the record date, issue price, entitlement ratio, and other terms. The deferment is due to the non-receipt of In-Principle Approval from BSE Limited for the proposed Rights Issue. The Board will reconvene to decide on these matters once the in-principle approval is obtained from the Exchange.
The deferment delays the Rights Issue process and may push back timelines for eligible shareholders to participate. The stock price could see short-term volatility as investors await clarity on the Rights Issue terms, though the decision is procedural and not indicative of any fundamental change.